Potential savings from greater use of $4 generic drugs.
作者信息
Zhang Yuting, Zhou Lei, Gellad Walid F
出版信息
Arch Intern Med. 2011 Mar 14;171(5):468-9. doi: 10.1001/archinternmed.2011.46.
Abstract
摘要
相似文献
1
Potential savings from greater use of $4 generic drugs.更多使用4美元通用药物可能带来的节省。
Arch Intern Med. 2011 Mar 14;171(5):468-9. doi: 10.1001/archinternmed.2011.46.
2
Brand-name versus generic drugs.品牌药与仿制药
Health Aff (Millwood). 2011 Oct;30(10):2027-8; author's reply 2028. doi: 10.1377/hlthaff.2011.0964.
3
Needed assumptions for potential savings from greater use of $4 generic drugs.更多使用4美元通用药物实现潜在节省所需的假设条件。
Arch Intern Med. 2011 Sep 26;171(17):1594-5; author reply 1595-6. doi: 10.1001/archinternmed.2011.410.
4
Prescription drugs and health care reform.处方药与医疗保健改革。
Pharmacotherapy. 1993 Nov-Dec;13(6):583-9.
5
Prescription drug costs and the generic dispensing ratio.处方药成本与仿制药配给率。
J Manag Care Pharm. 2010 Sep;16(7):502-6. doi: 10.18553/jmcp.2010.16.7.502.
6
[More than "cheap copies". Generic drugs promote medical progress].
MMW Fortschr Med. 2004 Jun 10;146(24):51.
7
The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money.在慢性病预防中使用通用药物比想象的更具成本效益，并且可能省钱。
Health Aff (Millwood). 2011 Jul;30(7):1351-7. doi: 10.1377/hlthaff.2010.0431.
8
Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans.在商业健康保险计划中，开始使用通用型与品牌型选择性5-羟色胺再摄取抑制剂（SSRI）或5-羟色胺-去甲肾上腺素再摄取抑制剂（SNRI）抗抑郁药的成年患者的停药率和医疗保健成本。
J Manag Care Pharm. 2011 Mar;17(2):123-32. doi: 10.18553/jmcp.2011.17.2.123.
9
Summaries for patients. Potential savings with substitution of generic drugs for brand-name drugs.
Ann Intern Med. 2005 Jun 7;142(11):I30. doi: 10.7326/0003-4819-142-11-200506070-00002.
10
Medicaid payment for generic drugs: achieving savings and access.医疗补助计划对非专利药的支付：实现成本节约与药物可及性
Issue Brief George Wash Univ Natl Health Policy Forum. 2010 Sep 30(839):1-16.
引用本文的文献
1
COVID-19 pandemic and initiation of treatment for atrial fibrillation: a nationwide analysis of claims data.COVID-19 大流行与心房颤动治疗的启动：一项全国性理赔数据分析。
BMC Cardiovasc Disord. 2023 Dec 8;23(1):604. doi: 10.1186/s12872-023-03614-z.
2
Empirical Assessment of the Impact of Low-Cost Generic Programs on Adherence-Based Quality Measures.低成本仿制药项目对基于依从性的质量指标影响的实证评估
Pharmacy (Basel). 2017 Mar 8;5(1):15. doi: 10.3390/pharmacy5010015.
3
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.欧美仿制药市场比较：价格、销量与支出
Milbank Q. 2017 Sep;95(3):554-601. doi: 10.1111/1468-0009.12279.
4
Estimation of Missed Statin Prescription Use in an Administrative Claims Dataset.在行政索赔数据集估算错过他汀类药物处方的使用情况。
J Manag Care Spec Pharm. 2017 Sep;23(9):936-942. doi: 10.18553/jmcp.2017.23.9.936.
5
Quantification of missing prescriptions in commercial claims databases: results of a cohort study.商业理赔数据库中缺失处方的量化：一项队列研究的结果
Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):386-392. doi: 10.1002/pds.4165. Epub 2017 Jan 25.
6
Small Ideas for Saving Big Health Care Dollars.节省巨额医疗费用的小妙招。
Rand Health Q. 2014 Mar 1;4(1):4. eCollection 2014 Spring.
7
The Prevalence and Predictors of Low-Cost Generic Program Use in the Pediatric Population.儿科人群中低成本仿制药使用的患病率及预测因素
Drugs Real World Outcomes. 2015;2(4):411-419. doi: 10.1007/s40801-015-0051-4. Epub 2015 Dec 1.
8
Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.在全国代表性的私人保险成年人队列中，低成本通用药物方案使用的流行率。
J Manag Care Spec Pharm. 2015 Dec;21(12):1162-70. doi: 10.18553/jmcp.2015.21.12.1162.
9
The relationship between violence in Northern Mexico and potentially avoidable hospitalizations in the USA-Mexico border region.墨西哥北部的暴力活动与美墨边境地区潜在可避免的住院治疗之间的关系。
J Public Health (Oxf). 2016 Mar;38(1):14-23. doi: 10.1093/pubmed/fdv012. Epub 2015 Feb 19.
10
Completeness of prescription information in US commercial claims databases.美国商业索赔数据库中处方信息的完整性。
Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):899-906. doi: 10.1002/pds.3458. Epub 2013 May 21.
Zotero 插件